Tolerability and efficacy study of P2X7 inhibition in experimental Charcot-Marie-Tooth type 1A (CMT1A) neuropathy-Reference-Cited by-同舟云学术

Tolerability and efficacy study of P2X7 inhibition in experimental Charcot-Marie-Tooth type 1A (CMT1A) neuropathy

Published:2016-11 Issue: Volume:95 Page:145-157
ISSN:0969-9961
Container-title:Neurobiology of Disease
language:en
Short-container-title:Neurobiology of Disease

Author:

Sociali Giovanna,Visigalli Davide,Prukop Thomas,Cervellini Ilaria,Mannino Elena,Venturi Consuelo,Bruzzone Santina^ORCID,Sereda Michael W.,Schenone Angelo

Funder

Telethon - Italy

University of Genova

German Ministry of Education and Research

Association Francaise contre Les Myopathies

European Leukodystrophie Society

Publisher

Elsevier BV

Subject

Neurology

Reference76 articles.

1. Physiological roles and potential therapeutic applications of the P2X7 receptor in inflammation and pain;Alves;Molecules,2013

2. Spinal cord pathology is ameliorated by P2X7 antagonism in a SOD1-mutant mouse model of amyotrophic lateral sclerosis;Apolloni;Dis. Model. Mech.,2014

3. P2X7 receptor blockade prevents ATP excitotoxicity in neurons and reduces brain damage after ischemia;Arbeloa;Neurobiol. Dis.,2012

4. A potential therapeutic role for P2X7 receptor (P2X7R) antagonists in the treatment of inflammatory diseases;Arulkumaran;Expert Opin. Investig. Drugs,2011

5. An exploratory randomised double-blind and placebo-controlled phase 2 study of a combination of baclofen, naltrexone and sorbitol (PXT3003) in patients with Charcot-Marie-Tooth disease type 1A;Attarian;Orphanet J. Rare Dis.,2014

Cited by 26 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Current Treatment Methods for Charcot–Marie–Tooth Diseases;Biomolecules;2024-09-09

2. Molecular mechanisms and therapeutic strategies for neuromuscular diseases;Cellular and Molecular Life Sciences;2024-04-28

3. Neural amyotrophy of Charcot-Marie-Tooth (clinical case);INTERNATIONAL NEUROLOGICAL JOURNAL;2023-11-08

4. Gene therapy and other novel treatment approaches for Charcot-Marie-Tooth disease;Neuromuscular Disorders;2023-08

5. The Current State of Charcot–Marie–Tooth Disease Treatment;Genes;2023-07-01